What is Basel Altaqi's NPI number?

Basel Altaqi's National Provider Identifier (NPI) is 1598703761, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Basel Altaqi's specialty?

Basel Altaqi is listed in the NPPES registry with a primary specialty of Pulmonary Disease Physician (Allopathic & Osteopathic Physicians).

Where is Basel Altaqi located?

Basel Altaqi's practice location on file with NPPES is 6707 Powers Blvd, Parma, OH 44129-5455.

What is Basel Altaqi's phone number?

The practice phone number listed in the NPPES registry for Basel Altaqi is (440) 886-2509.

Does Basel Altaqi accept Medicare?

Basel Altaqi is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Basel Altaqi's NPI active?

Yes — Basel Altaqi's NPI (1598703761) is active in the NPPES registry as of the last update on 2025-02-26.

IndividualActiveAccepts Medicare

Basel Altaqi, M.D.

NPI 1598703761 · Pulmonary Disease Physician · Parma, OH

Basel Altaqi, M.D. is a Pulmonary Disease Physician provider in Parma, OH (NPI 1598703761).

Provider details

NPI number: 1598703761
Entity type: Individual
Primary specialty: Pulmonary Disease PhysicianAllopathic & Osteopathic Physicians
Credential: M.D.
Sex: Male
Sole proprietor: No
License: 35085185 (OH)

Practice location

6707 Powers Blvd

Suite 106

Parma, OH 44129-5455

Phone: (440) 886-2509

Fax: (440) 886-2547

Street-level locationGet directions

More OH providers

Mailing address

6707 Powers Blvd

Parma, OH 44129-5455

Specialties & taxonomies

Pulmonary Disease PhysicianPrimary207RP1001XLicense 35085185 (OH)
Allopathic & Osteopathic Physicians
Critical Care Medicine (Internal Medicine) Physician207RC0200XLicense 35085185 (OH)
Allopathic & Osteopathic Physicians
Hospitalist Physician208M00000XLicense 39320 (KY)
Allopathic & Osteopathic Physicians
Hospitalist Physician208M00000XLicense 35085185 (OH)
Allopathic & Osteopathic Physicians

Enrolled with Medicare as Practitioner - Pulmonary Disease · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Detailed profile(94/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
20 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
3,499 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Subsequent Hospital Care With Moderate Levelof Medical Decision Making, If Using Time, at Least 35 Minutes99232	980	$78
Critical Care, First 30-74 Minutes99291	871	$211
Subsequent Hospital Care With Moderate Levelof Medical Decision Making, If Using Time, at Least 50 Minutes99233	373	$117
Initial Hospital Care With Moderate Level of Medical Decision Making, If Using Time, at Least 75 Minutes99223	235	$171
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	184	$88
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 29 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Fluticasone/Umeclidin/Vilanterbrand: Trelegy Ellipta	541	125
Albuterol Sulfatebrand: Albuterol Sulfate Hfa	271	97
Prednisone	188	97
Fluticasone/Vilanterolbrand: Breo Ellipta	103	13
Azithromycin	81	33
Umeclidinium Brm/Vilanterol Trbrand: Anoro Ellipta	60	20

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$249 across 7 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2006-06-02
Last updated: 2025-02-26
Certified: 2025-02-26

Frequently asked questions

What is Basel Altaqi's NPI number?: Basel Altaqi's National Provider Identifier (NPI) is 1598703761, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Basel Altaqi's specialty?: Basel Altaqi is listed in the NPPES registry with a primary specialty of Pulmonary Disease Physician (Allopathic & Osteopathic Physicians).
Where is Basel Altaqi located?: Basel Altaqi's practice location on file with NPPES is 6707 Powers Blvd, Parma, OH 44129-5455.
What is Basel Altaqi's phone number?: The practice phone number listed in the NPPES registry for Basel Altaqi is (440) 886-2509.
Does Basel Altaqi accept Medicare?: Basel Altaqi is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Basel Altaqi's NPI active?: Yes — Basel Altaqi's NPI (1598703761) is active in the NPPES registry as of the last update on 2025-02-26.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Subsequent Hospital Care With Moderate Levelof Medical Decision Making, If Using Time, at Least 35 Minutes99232	980	$78
Critical Care, First 30-74 Minutes99291	871	$211
Subsequent Hospital Care With Moderate Levelof Medical Decision Making, If Using Time, at Least 50 Minutes99233	373	$117
Initial Hospital Care With Moderate Level of Medical Decision Making, If Using Time, at Least 75 Minutes99223	235	$171
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	184	$88
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 29 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Fluticasone/Umeclidin/Vilanterbrand: Trelegy Ellipta	541	125
Albuterol Sulfatebrand: Albuterol Sulfate Hfa	271	97
Prednisone	188	97
Fluticasone/Vilanterolbrand: Breo Ellipta	103	13
Azithromycin	81	33
Umeclidinium Brm/Vilanterol Trbrand: Anoro Ellipta	60	20

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$249 across 7 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments